Evidence supporting the use of: Bifidobacterium longum
For the health condition: Inflammatory Bowel Disorders

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Bifidobacterium longum is a probiotic bacterium that has been the subject of numerous studies investigating its role in the management of Inflammatory Bowel Disorders (IBD), such as Crohn’s disease and ulcerative colitis. The rationale for its use is primarily scientific, supported by both preclinical and human studies, though the overall quality and consistency of evidence is moderate, hence a rating of 3 out of 5.

Mechanistically, B. longum has been shown to modulate the gut microbiota, enhance the intestinal barrier function, and exert anti-inflammatory effects by downregulating pro-inflammatory cytokines and upregulating anti-inflammatory mediators. Several clinical trials have evaluated the efficacy of B. longum—alone or in combination with other probiotics (such as in the VSL#3 formulation)—in patients with IBD. Some studies demonstrate that supplementation can reduce disease activity, improve clinical symptoms, and help maintain remission, particularly in ulcerative colitis and pouchitis. For example, a randomized controlled trial published in Gut (2004) showed that B. longum with prebiotics improved clinical and histological parameters in ulcerative colitis patients.

However, results are not universally positive, and studies often have limitations in sample size, heterogeneity in probiotic strains, and variations in study design. Systematic reviews and meta-analyses suggest a potential benefit, especially as an adjunct to conventional therapy, but call for more rigorous, large-scale studies. Thus, while scientific evidence exists, it is not yet definitive, and B. longum is generally considered as a supportive rather than primary therapy for IBD.

More about bifidobacterium longum
More about Inflammatory Bowel Disorders

Other ingredients used for Inflammatory Bowel Disorders

2'-Fucosyllactose
akkermansia muciniphila
algal oil
aloe vera
alpha-glycosyl isoquercitrin
alpha-linolenic acid (ALA)
anthocyanins
bacillus clausii
bacillus subtilis
barberry
barley
beta caryophyllene
bifidobacterium bifidum
bifidobacterium breve
bifidobacterium infantis
bifidobacterium lactis
bifidobacterium longum
butyrate triglyceride
cat's claw
chamomile
citrus pectin
Coptis chinensis
turmeric
curcumin
dandelion
DHA (docosahexaeonic acid)
EPA (eicosapentaenoic acid)
fish oil
flaxseed
fructooligosaccharides (FOS)
inulin
isomalto-oligosaccharide
l-glutamine
lactobacillus brevis
lactobacillus casei
lactobacillus crispatus
lactobacillus fermentum
lactobacillus gasseri
lactobacillus lactis
lactobacillus paracasei
lactiplantibacillus plantarum
lactobacillus reuteri
lactobacillus rhamnosus
lactobacillus salivarius
lactococcus lactis
licorice root
luteolin
marshmallow
n-acetyl-glucosamine
n-acetyl-cysteine (NAC)
nicotinamide riboside
omega-3 fatty acids
pectin
peppermint oil
butyric acid
psyllium
reishi mushroom
saccharomyces boulardii
shiitake mushroom
slippery elm bark
specialized pro-resolving mediators (SPMs)
spirulina
streptococcus thermophilus
tributyrin
Urolithin A
vitamin C
vitamin D
vitamin D3
xylanase
xylooligosaccharides
zinc
bentonite
punarnava
rubia cordifolia
swertia
myrrh
algae
7,14-Hydroxy-Docosapentaenoic Acid
Apigenin
Andrographolide
Avocado
anthocyanidins
Acemannan
Arabinoxylan
Apocynin
Arctiin
Astragalin
Bifidobacterium
Bifidobacterium adolescentis
Brassica
Boswellic Acid
Butternut
Basidiomycota
Boswellia
Bacillus licheniformis
Bioflavonoids
Bifidobacterium animalis
Bacteria
Bifidobacteria
Bacillus
Cichoric acid
Cruciferous
Casticin
Celandine
Chirata
Cannabidiol
Enterococcus
Eicosapentaenoic Acid
Ellagitannin